Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

NCT02996214 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

536

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Non-small-cell Lung Cancer

Interventions

DRUG: Paclitaxel Liposome
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Nanjing Luye Sike Pharmaceutical Co., Ltd.